Monthly Archives: May 2011

GoldLab Symposium Discusses Genomics, Rare Diseases, and More

The Second Annual GoldLab Symposium brought together a diverse group of presenters for a two day event. According to Larry Gold, the leader of the event and founder and CEO of Somalogic, this year’s event had a dual focus on the various “omics” – genomics, proteomics, transcriptionomics, etc – and on medical infrastructure and [...]

AmideBio Closes $575K Round

AmideBio announced that it has closed a $575,000 preferred equity financing round. The source of the funds was not disclosed. AmideBio uses proprietary “Cap-Clip” technology, exclusively licensed from the University of Colorado, to produce and commercialize technically challenging peptides. This technology has the potential to both lower costs and improve purity in peptide [...]

MicroPhage’s Rapid MRSA Test Approved by the FDA

The FDA announced the approval of the KeyPath MRSA/MSSA Blood Culture Test, manufactured by MicroPhage, Inc. The test can identify whether the bacteria in a patient’s blood culture sample is methicillin resistant (MRSA) or methicillin susceptible (MSSA) Staphylococcus aureus within five hours after the first bacterial growth in the sample – compared to the [...]